Lv31
310 积分 2024-04-26 加入
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
1小时前
待确认
Anti-BCMA CAR-T for the treatment of IgG4-related disease: clinical assessment and single-cell transcriptomic analysis
1个月前
已完结
Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy
1个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
2个月前
已完结
A Proposal for a Serology-Based Approach to Membranous Nephropathy
4个月前
已完结
Economic Evaluation of Rituximab Versus Corticosteroid‐Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea
4个月前
已完结
CAR T-cell therapy—paving the way for sensitized kidney transplant patients
6个月前
已完结
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis
6个月前
已完结
Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial
6个月前
已完结
Acute Kidney Injury in Hospitalised Cancer Patients: Incidence, Risk Factors and Outcomes
6个月前
已完结
皖公网安备34019202002308
